What is Orthogonal Thinker?
Orthogonal Thinker operates as a sophisticated holding entity dedicated to the acquisition and rapid scaling of organizations focused on psilocybin, psychoactive compounds, and plant sciences. By positioning itself at the intersection of mental wellness and emerging technology, the company distinguishes its portfolio through the strategic application of artificial intelligence and blockchain infrastructure. This methodology aims to standardize the development of plant medicine, providing a robust, data-driven foundation for mental health solutions that seek to elevate human well-being. The firm's market position is defined by its dual focus on scientific rigor and technological modernization, effectively bridging the gap between legacy botanical research and contemporary digital health ecosystems.
How much funding has Orthogonal Thinker raised?
Orthogonal Thinker has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2020): $6M with participation from Pay It Forward and Republic Labs
Key Investors in Orthogonal Thinker
Republic Labs
A venture capital firm specializing in early-stage technology investments and supporting high-growth startups through strategic capital and network access.
Pay It Forward
An investment group focused on backing mission-driven organizations that prioritize social impact alongside financial performance.
What's next for Orthogonal Thinker?
With the recent capital injection, Orthogonal Thinker is poised to enter a phase of aggressive operational scaling and portfolio expansion. The company is expected to leverage these funds to deepen its integration of blockchain-based transparency protocols and AI-driven research analytics across its acquired assets. As the regulatory landscape for psychoactive compounds continues to evolve, Orthogonal Thinker is strategically positioned to lead the institutionalization of plant medicine. Future growth will likely center on identifying high-potential acquisitions that align with its mission of empowering humanity through innovative health technologies, while simultaneously refining its internal governance to support long-term clinical and commercial viability in the global mental wellness market.
See full Orthogonal Thinker company page
